Literature DB >> 19594772

The potential role of C-reactive protein in distinguishing cytomegalovirus from tuberculosis and bacterial infections in renal transplant recipients.

Elerson C Costalonga1, Natalia C V Melo, Camila E Rodrigues, Luis H B C Sette, Luiz E Ianhez.   

Abstract

INTRODUCTION: The delay in the diagnosis of infections can be deleterious in renal transplant recipients. Thus, laboratory tests leading to an earlier diagnosis are very useful for these patients.
PURPOSE: To assess the behavior of C-reactive protein (CRP) in renal transplant recipients with a diagnosis of cytomegalovirus (CMV) infection, tuberculosis (TB) and bacterial infection (BI).
METHODS: A retrospective analysis of 129 patients admitted at our hospital, from 2006 to 2008 because of CMV, TB or BI, was carried out. Appropriate statistical analysis was done and values were expressed as medians, range.
RESULTS: When CRP levels were compared among the groups with CMV disease, TB or BI, the group with CMV disease presented lower levels of CRP (18.4 mg/L, 0.28-44 mg/L) than the TB and BI (p < 0.05) groups. The area under the receiver-operating characteristics curve, distinguishing CMV disease from TB/BI, was 0.96 (p < 0.0001), resulting in 100% sensitivity and 90.63% specificity to detect CMV disease when CRP < 44.5 mg/L. The subgroup analysis of CMV infection showed increasing levels of CRP (0.28, 16 and 29.5 mg/L) in the asymptomatic, symptomatic and invasive disease subgroups, respectively (p < 0.05).
CONCLUSION: The measurement of CRP levels may be a useful tool for differentiating CMV infection from the other types (bacterial or TB) of infection in kidney transplant recipients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19594772     DOI: 10.1111/j.1399-0012.2009.01030.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  3 in total

1.  Clinical characteristics and computed tomography findings of pulmonary toxoplasmosis after hematopoietic stem cell transplantation.

Authors:  Masahiko Sumi; Kazumi Norose; Kenji Hikosaka; Hiroko Kaiume; Wataru Takeda; Takehiko Kirihara; Taro Kurihara; Keijiro Sato; Toshimitsu Ueki; Yuki Hiroshima; Hiroshi Kuraishi; Masahide Watanabe; Hikaru Kobayashi
Journal:  Int J Hematol       Date:  2016-08-16       Impact factor: 2.490

2.  Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States.

Authors:  Amanda M Simanek; Jennifer Beam Dowd; Graham Pawelec; David Melzer; Ambarish Dutta; Allison E Aiello
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

3.  Mycobacterium tuberculosis infection following kidney transplantation.

Authors:  Karima Boubaker; Tahar Gargah; Ezzedine Abderrahim; Taieb Ben Abdallah; Adel Kheder
Journal:  Biomed Res Int       Date:  2013-10-08       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.